Clinical Trials Browser

Refractory Solid Tumors × Sorafenib × Clear all

NCT02691780 2019-12-30

Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors

Phase NA Withdrawn

Other solid neoplasm

Refractory Solid Tumors

NCT02450149 2017-03-13

Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors

Phase NA Completed

Other solid neoplasm

Refractory Solid Tumors

NCT00759928 2014-07-02

PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors

Phase 1 Completed

Other solid neoplasm

Refractory Solid Tumors